EGFR and neoplasm: Encouraging results have been obtained in this context by the group of Krug et al., who demonstrated increased sensitivity in detecting EGFR mutations in the plasma of lung cancer patients with a combined analysis of circulating tumor and EV DNA compared to circulating tumor DNA alone [109].